Dr. Michael Bruce Gorin, MD

Dr. Gorin practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Gorin's NPI, 1578536462, was assigned on February 10, 2006. Dr. Gorin graduated from Perelman School of Medicine - Philadelphia in 1980. Dr. Gorin's California license number on file is G45424.

Dr. Gorin's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Gorin's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Gorin is also affiliated with Ronald Reagan UCLA Medical Center. Dmand AI also links Dr. Gorin to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gorin practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Gorin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Gorin is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Gorin's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, dry eye, eye infection or inflammation, eyelid inflammation, hypertensive retinopathy, retinal detachment and retinal occlusion among the conditions Dr. Gorin treats.

CMS data shows 2,027 Medicare services from Dr. Gorin across 9 procedure codes in 2024, for 408 Medicare patients. Medicare paid $114,114 for them.

CMS counts 408 Medicare patients who saw Dr. Gorin in 2024. The largest group is 75 to 84, with 163 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gorin's median patient age at 64, with 58% women.

In 2024, Dr. Gorin wrote 280 Medicare Part D claims for 59 patients. 73% of them were for generic drugs. CMS names the drug for 203 of them, across 7 drugs with 11 or more claims each, at $12,587 in total drug cost. In 2023, CMS named 316 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Gorin for performance year 2024, reported as part of a group. Dr. Gorin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gorin as offering telehealth.

Dmand AI links 43 papers to Dr. Gorin, published from 2011 to 2025. 2015 was the busiest year, with 6. Dr. Gorin's most frequent co-authors are Matthew Brooks, MD, John Robert Heckenlively, MD and Ivana K. Kim, MD.

Dmand AI links Dr. Gorin to 4 clinical trials. 3 are still active or recruiting. Conditions studied include Geographic Atrophy, Retinal Diseases and Stargardt Disease. University of California, Los Angeles sponsors the most, 2.

CMS Open Payments shows 9 general payments to Dr. Gorin from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 99% of the total. Genentech, Inc. paid the most, $5,000.

Dmand AI lists 16 awards for Dr. Gorin, most recently America's Top Doctors in 2014.

Dr. Gorin graduated from Perelman School of Medicine - Philadelphia in 1980. Dr. Gorin is a member of AAO.

Dr. Gorin is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.